Published: Less than 30 min ago
Groundbreaking progress has been made in vaccine research for diseases such as cancer, tumors and autoimmune diseases thanks to knowledge gained during the pandemic. This is stated by several pharmaceutical companies for The Guardian.
According to several pharmaceutical companies, several new vaccines could be in place within just ten years.
Moderna has recently conducted several studies on different types of vaccines and the pharmaceutical company’s chief physician, Paul Burto, is hopeful that it will be able to present several new vaccine types before the end of the decade, writes The Guardian.
Some researchers have stated that upwards of 15 years of research was earned in just 12–18 months during the intense pandemic years.
– I think we will be able to offer vaccines against several types of tumors to people globally, he says to The Guardian.
One of the successes he attributes to the discovery of the mRNA vaccine.
– It can be applied to all possible types of disease areas; cancer, infectious diseases, cardiovascular diseases and autoimmune diseases.
The pharmaceutical company Pfizer also says that it has gained many important experiences and has been able to streamline its vaccine research after the pandemic. In a statement it is written:
“The lessons learned from the covid-19 vaccine development have given us broader information about our overall approach to mRNA research and development, and how Pfizer conducts research and development more broadly. We gained a decade of scientific knowledge in just one year”.